AU507272B2 - Pharmaceutical compositions and compounds - Google Patents

Pharmaceutical compositions and compounds

Info

Publication number
AU507272B2
AU507272B2 AU15540/76A AU1554076A AU507272B2 AU 507272 B2 AU507272 B2 AU 507272B2 AU 15540/76 A AU15540/76 A AU 15540/76A AU 1554076 A AU1554076 A AU 1554076A AU 507272 B2 AU507272 B2 AU 507272B2
Authority
AU
Australia
Prior art keywords
compounds
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU15540/76A
Other versions
AU1554076A (en
Inventor
C. Pendleton R. G. and Setler F. E Kaiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/592,708 external-priority patent/US4011319A/en
Priority claimed from US05/602,042 external-priority patent/US4052506A/en
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of AU1554076A publication Critical patent/AU1554076A/en
Application granted granted Critical
Publication of AU507272B2 publication Critical patent/AU507272B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU15540/76A 1975-07-02 1976-07-02 Pharmaceutical compositions and compounds Expired AU507272B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
USUS592,708 1975-07-02
US05/592,708 US4011319A (en) 1975-07-02 1975-07-02 Pharmaceutical compositions and methods involving benzazepine derivatives
US05/602,042 US4052506A (en) 1975-08-05 1975-08-05 Pharmaceutical compositions and method of producing anti-parkinsonism activity
USUS602,042 1975-08-05

Publications (2)

Publication Number Publication Date
AU1554076A AU1554076A (en) 1978-01-05
AU507272B2 true AU507272B2 (en) 1980-02-07

Family

ID=27081519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15540/76A Expired AU507272B2 (en) 1975-07-02 1976-07-02 Pharmaceutical compositions and compounds

Country Status (10)

Country Link
JP (1) JPS527981A (en)
AU (1) AU507272B2 (en)
CA (1) CA1079639A (en)
DE (1) DE2629887A1 (en)
FR (1) FR2315934A1 (en)
GB (1) GB1561305A (en)
IE (1) IE43920B1 (en)
IL (1) IL49931A (en)
LU (1) LU75269A1 (en)
NL (1) NL7607184A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104379A (en) * 1977-01-19 1978-08-01 Smithkline Corporation Substituted 1-alkylthiophenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
ZA777444B (en) * 1977-01-19 1978-10-25 Smithkline Corp Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines having dopaminergic activity
US4490392A (en) * 1977-08-11 1984-12-25 Tanabe Seiyaku Co., Ltd. Benzylalcohol derivative and process for preparing
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ATE5634T1 (en) * 1979-07-10 1984-01-15 Smithkline Beckman Corporation SYNERGISTIC ANTOPRESSOR COMPOSITIONS.
EP0103830A3 (en) * 1982-09-22 1985-07-31 Bayer Ag Phenylethylemine derivatires as growth stimulators
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
JP2006526021A (en) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 5H-benzo [D] naphtho [2,1-B] azepine derivatives as selective D1 / D5 receptor antagonists to treat obesity and CNS disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines

Also Published As

Publication number Publication date
IL49931A (en) 1981-12-31
FR2315934B1 (en) 1978-11-17
NL7607184A (en) 1977-01-04
LU75269A1 (en) 1977-02-18
IL49931A0 (en) 1976-08-31
CA1079639A (en) 1980-06-17
GB1561305A (en) 1980-02-20
FR2315934A1 (en) 1977-01-28
AU1554076A (en) 1978-01-05
JPS527981A (en) 1977-01-21
DE2629887A1 (en) 1977-01-20
IE43920L (en) 1977-01-02
IE43920B1 (en) 1981-07-01

Similar Documents

Publication Publication Date Title
JPS5272829A (en) Pharmaceutical composition
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ181010A (en) Heteroaryl compounds and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
AU502644B2 (en) Xanthine-containing pharmaceutical compositions
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
AU507272B2 (en) Pharmaceutical compositions and compounds
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
AU504840B2 (en) Medicinal compositions
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
AU505476B2 (en) Pharmaceutical composition
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
GB1539031A (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
AU499217B2 (en) Pharmaceutical compositions
PH11642A (en) Benzocycloheptothiophenes and pharmaceutical compositions
NZ181626A (en) 3-holo-cephalosporins and pharmaceutical compositions